Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 2, 2012, Pages 291-299

  Rousseau, Caroline ^a,b   Rousseau, Thierry ^c   Bridji, Boumédiène ^a   Pallardy, Amandine ^a   Lacoste, Jacques ^c   Campion, Loïc ^a   Testard, Aude ^a   Aillet, Geneviève ^d   Mouaden, Ayat ^a   Curtet, Chantal ^b   Kraeber Bodéré, Françoise ^a,b  

^a Nantes St Herblain and Centre de Recherche en Cancérologie et Immunologie   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Clinique urologique Nantes Atlantis   (France)

^d Anatomopathologie   (France)

Author keywords

Extended pelvic lymph node dissection; Laparoscopic surgery; Prostate cancer; Sentinel lymph node

Indexed keywords

HEMATOXYLIN; PHLOXINE; RHENIUM SULFIDE COLLOID TC 99M;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; CROCUS SATIVUS; EX VIVO STUDY; HIGH RISK PATIENT; HISTOLOGY; HUMAN; ILIAC CREST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS SURGERY; PRIMARY TUMOR; PROSPECTIVE STUDY; PROSTATE CARCINOMA; SENTINEL LYMPH NODE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; URETEROPELVIC JUNCTION;

ADULT; AGED; CARCINOMA; COLLOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; PROGNOSIS; PROSTATIC NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 84859627106     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1975-x     Document Type: Article

References (37)

1. Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000;31:578-83. (Pubitemid 30323983)
2. Cheng L, Zincke H, Blute M, Bergstralh E, Scherer B, Bostwick D. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001;91:66-73. (Pubitemid 32052615)
3. Heidenreich A, Aus G, Bolla M, Joniau S, Matveer VB, Schmid HP, et al. EAU guidelines on prostate cancer. Eur Urol 2008;53:68-80. (Pubitemid 350166735)
4. Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006;50:1006-13. (Pubitemid 44486500)
5. Moul JW. Will the global economic downturn affect prostate cancer care? Pelvic lymphadenectomy as an example. Eur Urol 2009;55:1266-8.
6. Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer. Semin Nucl Med 1999;29:57-60.
7. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg 1999;134:764-7. (Pubitemid 29316117)
8. McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001;234:292-300. (Pubitemid 32847066)
9. Tafra L, McMaster KM, Whitworth P, Edwards MJ. Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 2000;180:268-73.
10. D'Amico AV, Whittington R, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A. Outcome based staging for clinically localized adenocarcinoma of the prostate. J Urol 1997;158:1422-6. (Pubitemid 27391211)
11. Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2005;173:1943-6. (Pubitemid 40675217)
12. Häcker A, Jeschke S, Leeb K, Prammer K, Ziegerhofer J, Sega W, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2006;176:2014-8.
13. Corvin S, Schilling D, Eichhorn K, Hundt I, Hennenlotter J, Anastasiadis AG, et al. Laparoscopic sentinel lymph node dissection - a novel technique for the staging of prostate cancer. Eur Urol 2006;49:280-5. (Pubitemid 43197865)
14. Meinhardt W, Valdés Olmos RA, van der Poel HG, Bex A, Horenblas S. Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int 2008;102:714-7.
15. Jeschke S, Beri A, Grüll M, Ziegerhofer J, Prammer P, Leeb K, et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 2008;53:126-32.
16. Vermeeren L, Valdés Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med 2009;50:865-70.
17. Schilling D, Boekeler U, Gakis G, Schwentner C, Corvin S, Sotlar K, et al. Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer. World J Urol 2010;28:715-20.
18. Vermeeren L, Muller SH, Meinhardt W, Valdés Olmos RA. Optimizing the colloid concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer. Eur J Nucl Med Mol Imaging 2010;37:1328-34.
19. Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE. Detection rate and operating time required for gamma probeguided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol 2007;52:126-32.
20. Kroon BK, Horenblas S, Meinhardt W, van der Poel HG, Bex A, van Tinteren H, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 2005;47:601-6. (Pubitemid 40521903)
21. Bastide D, Brenot-Rossi I, Garcia S, Dumas S, Anfossi E, Ragni E, et al. Faisabilité et intérêt de la technique isotopique du ganglion sentinelle dans le cancer de la prostate. Prog Urol 2004;4:501-6. (Pubitemid 39468301)
22. Brenot-Rossi I, Bastide C, Garcia S, Dumas S, Esterni B, Pasquier J, et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 2005;32:635-40. (Pubitemid 40897484)
23. Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C. Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radio-labelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging 2008;35:32-8. (Pubitemid 350234133)
24. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 2009;36:1377-82.
25. van der Poel HG, Buckle T, Brouwer OR, Valdés Olmos RA, van Leeuwen FW. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 2011;60:826-33.
26. Salomon L, Azria D, Bastide C, Beuzeboc P, Cormier L, Cornud F, et al. Recommandations en onco-urologie 2010: cancer de prostate. Prog Urol 2010;20 Suppl 4:S217-51.
27. Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 2007;177:916-20. (Pubitemid 46216337)
28. Vermeeren L, Valdés Olmos RA, Meinhardt W, Horenblas S. Intraoperative imaging for sentinel node identification in prostate carcinoma: its use in combination with other techniques. J Nucl Med 2011;52:741-4.
29. Wagner M, Sokoloff M, Daneshmand S. The role of pelvic lymphadenectomy for prostate cancer - therapeutic? J Urol 2008;179:408-13.
30. Egawa M, Fukuda M, Takashima H, Misaki T, Kinuya K, Terahata S. The sentinel node concept in prostate cancer: present reality and future prospects. Indian J Urol 2008;24:451-6.
31. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007;13:4807-16. (Pubitemid 47294788)
32. Fujisawa M, Miyake H. Significance of micrometastases in prostate cancer. Surg Oncol 2008;17:247-52.
33. Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30:807-16. (Pubitemid 39186065)
34. Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil M, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 2003;70:303-10. (Pubitemid 36566262)
35. Lyman GH, Giuliano AE, Somerfield MR, Benson 3rd AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20. (Pubitemid 46291835)
36. Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 2004;171:2268-71. (Pubitemid 38625449)
37. Burkhard FC, Schumacher M, Studer UE. The role of lymphadenectomy in prostate cancer. Nat Clin Pract Urol 2005;2:336-42. (Pubitemid 41122582)